Madder Ryan D, Seth Milan, Sukul Devraj, Yelavarthy Prasanthi, Pielsticker Elizabeth, Gribar John, Kumar Sabina, Zainea Mark, Croce Kevin, Shlofmitz Evan, Wanamaker Brett, Gurm Hitinder S
Department of Cardiovascular Medicine, William Beaumont University Hospital, Corwell Health East, Royal Oak, Michigan.
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
J Soc Cardiovasc Angiogr Interv. 2025 May 1;4(7):103710. doi: 10.1016/j.jscai.2025.103710. eCollection 2025 Jul.
This study assessed the temporal trend in intracoronary imaging (ICI)-guided percutaneous coronary intervention (PCI) concurrent with the implementation of a statewide quality improvement initiative to increase ICI use.
The Blue Cross Blue Shield of Michigan Cardiovascular Consortium implemented a formal initiative to increase ICI use for PCI optimization in the state of Michigan between 2020 and 2023. The initiative included focused education for physicians, reporting of comparative institution-level ICI use, and tracking of ICI use as a performance metric. The primary measure of interest was the use of ICI to optimize PCI. A hierarchical Bayesian regression model was created to assess the increase in ICI use over time. The year in which a PCI was performed was included as a variable in the model to delineate the impact of time on the odds of ICI use.
Over the 5-year study period, a total of 140,739 PCIs were performed at 48 nonfederal hospitals in Michigan and represented the study population. A progressive and significant increase in ICI use to optimize PCI was observed from 7.3% in the first year to 44.0% in the fifth year of the study ( < .001 for trend). Significant increases in ICI use were observed for all key subgroups including PCI in left main disease (19.3% to 78.5%; < .001), stent thrombosis (13.6% to 61.4%; < .001), and in-stent restenosis (8.7% to 50.6%; < .001). Each 1-year increase in time was associated with a significant increase in ICI use (adjusted odds ratio, 1.98; 95% credible interval, 1.95-2.00).
Concurrent with a statewide quality improvement initiative, a significant increase in ICI use to optimize PCI was observed among patients undergoing PCI in the state of Michigan.
本研究评估了冠状动脉内成像(ICI)引导的经皮冠状动脉介入治疗(PCI)的时间趋势,同时实施了一项全州范围的质量改进计划以增加ICI的使用。
密歇根蓝十字蓝盾心血管联盟在2020年至2023年期间实施了一项正式计划,以增加ICI在密歇根州用于优化PCI的使用。该计划包括针对医生的重点教育、机构层面ICI使用情况的比较报告以及将ICI使用情况作为一项绩效指标进行跟踪。主要关注的指标是使用ICI来优化PCI。创建了一个分层贝叶斯回归模型来评估ICI使用随时间的增加情况。进行PCI的年份作为变量纳入模型,以描述时间对ICI使用几率的影响。
在为期5年的研究期间,密歇根州48家非联邦医院共进行了140,739例PCI,构成了研究人群。从研究的第一年到第五年,观察到使用ICI优化PCI的情况有渐进且显著的增加,从7.3%增至44.0%(趋势P<0.001)。在所有关键亚组中,ICI使用均显著增加,包括左主干病变的PCI(从19.3%增至78.5%;P<0.001)、支架血栓形成(从13.6%增至61.4%;P<0.001)以及支架内再狭窄(从8.7%增至50.6%;P<0.001)。时间每增加1年,ICI使用就显著增加(调整后的优势比为1.98;95%可信区间为1.95 - 2.00)。
在全州范围的质量改进计划实施的同时,密歇根州接受PCI的患者中,使用ICI优化PCI的情况显著增加。